Chonnam Med J.  2003 Mar;39(1):37-40.

Experience of Intracorporeal Injection Therapy in the Era of Oral Sildenafil

• Park SH
• Kang TW
• Park K

Abstract

The aim of this study was to evaluate the outcome of intracorporeal injection (ICI) therapy in the era of oral sidenafil for erectile dysfunction. A total of 118 impotent patients who received intracorporeal injections of triple agents (papaverine plus phentolamine and prostaglandin E1) for more than 3 months were retrospectively recruited for the study. The dose of the triple agent and duration of erection were evaluated. And the patient preference for choosing ICI or oral sildenafil citrate was also assessed. The age of the subjects ranged from 24 to 76 years (mean 53 years). Of the 118 patients 10 (8.4%) dropped out of the study. The treatment dose and duration of erection did not change significantly between the initial treatment and after 3 months of treatment (p > 0.05). After 3 months of ICI therapy, 75 responders (63.6%) continued to choose ICI therapy, where as, 33 (28.0%) switched to oral therapy. In the era of oral medications for treating erectile dysfunction, ICI therapy still remains to be preferred by a large number of patients.

Keyword

Erectile dysfunction; Intracorporeal injection; Sildenafil

MeSH Terms

Citric Acid
Erectile Dysfunction
Humans
Male
Patient Preference
Phentolamine
Retrospective Studies
Citric Acid
Phentolamine